Evidence map›Paper›PMID 32535819›Full record

ArticleRadiological physics and technology2020

Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.

Kazuki Motegi, Norikazu Matsutomo, Tomoaki Yamamoto, Mitsuru Koizumi

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Progress in diagnosis of bone metastasis of prostate cancer.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kazuki MotegiDepartment of Nuclear Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-11 Ariake, Koto-ku, Tokyo, 135-8550, Japan. kazuki.motegi@jfcr.or.jp.
Norikazu MatsutomoGraduate School of Health Sciences, Department of Medical Radiological Technology, Faculty of Health Sciences, Kyorin University, A-420, 5-4-1 Shimorenjaku Mitaka-shi, Tokyo, 181-8612, Japan.
Tomoaki YamamotoGraduate School of Health Sciences, Department of Medical Radiological Technology, Faculty of Health Sciences, Kyorin University, A-420, 5-4-1 Shimorenjaku Mitaka-shi, Tokyo, 181-8612, Japan.
Mitsuru KoizumiDepartment of Nuclear Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-11 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Japanese Foundation For Cancer Research · JPTokyo Ariake University of Medical and Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic bone volume (MBV), standardized uptake value (SUV), and total bone uptake (TBU) are new imaging biomarkers for quantitative bone single-photon emission computed tomography/computed tomography. The purpose of this study was to validate the quantitative accuracy and utility of MBV, SUV

Indexed as

Phantoms, ImagingSingle Photon Emission Computed Tomography Computed TomographyTumor BurdenAgedAged, 80 and overBone NeoplasmsHumansMaleMiddle AgedProstatic NeoplasmsRetrospective StudiesSurvival AnalysisBone scintigraphyProstate cancerQuantitative SPECT/CTTumor response

Identifiers

PMID32535819
OpenAlexW3034914362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.